Evidence map›Paper›PMID 28356160›Full record

ArticleJournal of nanobiotechnology2017

Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs.

Philipp Nold, Raimo Hartmann, Neus Feliu, Karsten Kantner, Mahmoud Gamal, Beatriz Pelaz, Jonas Hühn, Xing Sun, Philipp Jungebluth, Pablo Del Pino and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Quantitative Particle Uptake by Cells as Analyzed by Different Methods.Angewandte Chemie (International ed. in English) · 2020
    Review
  13. Article
  14. Article
  15. Nanoscale advances · 2019
    Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Philipp NoldDepartment of Hematology, Oncology and Immunology, Philipps University Marburg, Marburg, Germany.
Raimo HartmannDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Neus FeliuDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Karsten KantnerDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Mahmoud GamalDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Beatriz PelazDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Jonas HühnDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Xing SunDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Philipp JungebluthThoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Pablo Del PinoDepartment of Physics, Philipps-University of Marburg, Marburg, Germany.
Holger HacksteinInstitute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen, Giessen, Germany.
Paolo MacchiariniLaboratory of Bioengineering & Regenerative Medicine (BioReM), Kazan Federal University, Kazan, Russia.
Wolfgang J ParakDepartment of Physics, Philipps-University of Marburg, Marburg, Germany. wolfgang.parak@physik.uni-marburg.de.
Cornelia BrendelDepartment of Hematology, Oncology and Immunology, Philipps University Marburg, Marburg, Germany. brendelc@staff.uni-marburg.de.ORCID http://orcid.org/0000-0003-1612-9557
Philipps University of Marburg · DEHeidelberg University · DEJustus-Liebig-Universität Gießen · DEKazan Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenchymal stromal cells (MSCs) have an inherent migratory capacity towards tumor tissue in vivo. With the future objective to quantify the tumor homing efficacy of MSCs, as first step in this direction we investigated the use of inorganic nanoparticles (NPs), in particular ca. 4 nm-sized Au NPs, for MSC labeling. Time dependent uptake efficiencies of NPs at different exposure concentrations and times were determined via inductively coupled plasma mass spectrometry (ICP-MS).

resultsThe labeling efficiency of the MSCs was determined in terms of the amount of exocytosed NPs versus the amount of initially endocytosed NPs, demonstrating that at high concentrations the internalized Au NPs were exocytosed over time, leading to continuous exhaustion. While exposure to NPs did not significantly impair cell viability or expression of surface markers, even at high dose levels, MSCs were significantly affected in their proliferation and migration potential. These results demonstrate that proliferation or migration assays are more suitable to evaluate whether labeling of MSCs with certain amounts of NPs exerts distress on cells. However, despite optimized conditions the labeling efficiency varied considerably in MSC lots from different donors, indicating cell specific loading capacities for NPs. Finally, we determined the detection limits of Au NP-labeled MSCs within murine tissue employing ICP-MS and demonstrate the distribution and homing of NP labeled MSCs in vivo.

conclusionAlthough large amounts of NPs improve contrast for imaging, duration and extend of labeling needs to be adjusted carefully to avoid functional deficits in MSCs. We established an optimized labeling strategy for human MSCs with Au NPs that preserves their migratory capacity in vivo.

Indexed as

Cell TrackingAnimalsCell DifferentiationCell MovementCells, CulturedCell SurvivalEndocytosisExocytosisGoldHumansMaleMass SpectrometryMesenchymal Stem CellsMetal NanoparticlesMiceMice, Inbred BALB CGoldAu nanoparticles (Au NP), labeling, in vivo trackingMesenchymal stromal cells (MSCs)

Identifiers

PMID28356160
PMCPMC5372278
OpenAlexW2599381953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.